会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Tobacco reconstitution process
    • 烟草重组过程
    • US5533530A
    • 1996-07-09
    • US299870
    • 1994-09-01
    • Harvey J. YoungThomas W. BrownSara W. DevineThomas A. Perfetti
    • Harvey J. YoungThomas W. BrownSara W. DevineThomas A. Perfetti
    • A24B3/14A24B15/12A24B15/24A24B15/26D21F3/02
    • A24B15/12A24B15/24
    • The process of the present invention involves extracting components from a tobacco material or other plant material using a solvent having an aqueous character to provide separately an aqueous tobacco extract and a water insoluble tobacco portion. The insoluble tobacco portion is refined and a slurry is produced. The slurry is formed into a predetermined shape, e.g., a formed web. The formed web can be pressed to reduce the moisture content. The tobacco material preferably has a moisture content of at least about 50 percent by weight. The material is contacted with an aqueous mixture of an aerosol precursor material. The ratio of liquid having an aqueous character to aerosol precursor material is typically from about 25 to 75 percent by weight. Immediately after the introduction of the aerosol precursor material, the web is dried at a preselected temperature so that the aerosol precursor material is dispersed evenly throughout the web.
    • 本发明的方法包括使用具有水性特征的溶剂从烟草材料或其它植物材料中提取组分以分别提供含水烟草提取物和水不溶性烟草部分。 将不溶性烟草部分精制并制备浆料。 将浆料形成为预定形状,例如形成的网。 可以压制形成的网以减少水分含量。 烟草材料优选具有至少约50重量%的水分含量。 将材料与气溶胶前体材料的水性混合物接触。 具有水性特征的液体与气溶胶前体材料的比率通常为约25至75重量%。 在引入气溶胶前体材料之后立即在预选温度下干燥网,使得气溶胶前体材料均匀地分散在整个幅材上。
    • 9. 发明授权
    • Device and method for delivering an aerosol drug
    • 用于递送气溶胶药物的装置和方法
    • US08251060B2
    • 2012-08-28
    • US11903342
    • 2007-09-21
    • Jackie L. WhiteThomas A. Perfetti
    • Jackie L. WhiteThomas A. Perfetti
    • A61M15/00
    • A61M11/041A61M11/001A61M11/042A61M15/06A61M2205/8268
    • A device and method for delivering a therapeutic drug to a patient in the form of an aerosol includes a heat generating chamber and an aerosol forming chamber separated by a heat conductor. A heating element is disposed within the heat generating chamber in heat conducting relation with the heat conductor. A substrate having a therapeutic drug and an aerosol forming agent deposited thereon is disposed within the aerosol forming chamber in heat conducting relation with the heat conductor. The heating element ignites a fuel source consisting essentially of a combustible liquefied gas to generate heat that is conducted to the heat conductor and then to the substrate via the heat conductor. The heat generated by the heating element activates the aerosol forming agent to volatilize the therapeutic drug into an aerosol drug contained within the aerosol forming chamber and made available to be inhaled by the patient.
    • 用于将治疗药物以气溶胶形式递送给患者的装置和方法包括由热导体隔开的发热室和气溶胶形成室。 加热元件设置在发热室内与导热体导热的关系。 具有沉积在其上的治疗药物和气溶胶形成剂的基底设置在气溶胶形成室内与导热体导热的关系。 加热元件点燃基本上由可燃液化气体组成的燃料源,以产生通过热导体传导到热导体然后传递到基底的热量。 由加热元件产生的热量激活气溶胶形成剂,以将治疗药物挥发成气溶胶形成室内所含的气溶胶药物,并使其可被患者吸入。